PortfoliosLab logoPortfoliosLab logo
CYTK vs. QQQ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CYTK vs. QQQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cytokinetics, Incorporated (CYTK) and Invesco QQQ ETF (QQQ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CYTK achieves a 33.57% return, which is significantly higher than QQQ's 18.38% return. Over the past 10 years, CYTK has outperformed QQQ with an annualized return of 23.96%, while QQQ has yielded a comparatively lower 21.45% annualized return.


CYTK

1D
-1.39%
1M
20.98%
6M
35.77%
YTD
33.57%
1Y
129.32%
3Y*
34.18%
5Y*
34.07%
10Y*
23.96%

QQQ

1D
0.31%
1M
0.69%
6M
16.05%
YTD
18.38%
1Y
31.54%
3Y*
26.10%
5Y*
15.67%
10Y*
21.45%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CYTK vs. QQQ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CYTK
Cytokinetics, Incorporated
33.57%35.08%-43.66%82.21%0.53%119.35%95.85%67.88%-22.45%-32.92%
QQQ
Invesco QQQ ETF
18.38%20.77%25.58%54.86%-32.58%27.42%48.62%38.96%-0.13%32.66%

Correlation

The correlation between CYTK and QQQ is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (10Y)
Calculated over the trailing 10-year period

0.31

Correlation (All Time)
Calculated using the full available price history since Apr 29, 2004

0.33

The correlation between CYTK and QQQ shifts across timeframes, from 0.20 (3 years) to 0.33 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CYTK vs. QQQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CYTK
CYTK Risk / Return Rank: 9595
Overall Rank
CYTK Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
CYTK Sortino Ratio Rank: 9595
Sortino Ratio Rank
CYTK Omega Ratio Rank: 9393
Omega Ratio Rank
CYTK Calmar Ratio Rank: 9898
Calmar Ratio Rank
CYTK Martin Ratio Rank: 9797
Martin Ratio Rank

QQQ
QQQ Risk / Return Rank: 6464
Overall Rank
QQQ Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
QQQ Sortino Ratio Rank: 6060
Sortino Ratio Rank
QQQ Omega Ratio Rank: 6262
Omega Ratio Rank
QQQ Calmar Ratio Rank: 6666
Calmar Ratio Rank
QQQ Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CYTK vs. QQQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cytokinetics, Incorporated (CYTK) and Invesco QQQ ETF (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CYTKQQQDifference
Sharpe ratioReturn per unit of total volatility

+0.49

Sortino ratioReturn per unit of downside risk

+1.32

Omega ratioGain probability vs. loss probability

1.42

1.30

+0.12

Calmar ratioReturn relative to maximum drawdown

8.84

2.62

+6.22

Martin ratioReturn relative to average drawdown

19.45

9.43

+10.01

CYTK vs. QQQ - Sharpe Ratio Comparison

The current CYTK Sharpe Ratio is 2.19, which is comparable to the QQQ Sharpe Ratio of 1.70. The chart below compares the historical Sharpe Ratios of CYTK and QQQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CYTK vs. QQQ - Drawdown Comparison

The maximum CYTK drawdown since its inception was -97.09%, which is greater than QQQ's maximum drawdown of -82.97%. Use the drawdown chart below to compare losses from any high point for CYTK and QQQ.


Loading charts...

Drawdown Indicators


CYTKQQQDifference

Max Drawdown

Largest peak-to-trough decline

-97.09%

-82.97%

-14.12%

Max Drawdown (1Y)

Largest decline over 1 year

-15.01%

-11.96%

-3.05%

Max Drawdown (3Y)

Largest decline over 3 years

-72.39%

-22.77%

-49.62%

Max Drawdown (5Y)

Largest decline over 5 years

-72.39%

-35.12%

-37.27%

Max Drawdown (10Y)

Largest decline over 10 years

-72.39%

-35.12%

-37.27%

Current Drawdown

Current decline from peak

-21.46%

-2.66%

-18.80%

Average Drawdown

Average peak-to-trough decline

-75.82%

-32.67%

-43.15%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.81%

3.32%

+3.49%

Volatility

CYTK vs. QQQ - Volatility Comparison

Cytokinetics, Incorporated (CYTK) has a higher volatility of 10.02% compared to Invesco QQQ ETF (QQQ) at 8.71%. This indicates that CYTK's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CYTKQQQDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.02%

8.71%

+1.31%

Volatility (6M)

Calculated over the trailing 6-month period

32.41%

15.28%

+17.13%

Volatility (1Y)

Calculated over the trailing 1-year period

60.74%

18.47%

+42.27%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

70.03%

22.77%

+47.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

68.02%

22.43%

+45.59%

Dividends

CYTK vs. QQQ - Dividend Comparison

CYTK has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.42%.


PositionTTM20252024202320222021202020192018201720162015
CYTK
Cytokinetics, Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
QQQ
Invesco QQQ ETF
0.42%0.45%0.56%0.62%0.80%0.43%0.55%0.74%0.91%0.84%1.06%0.99%

Frequently Asked Questions


CYTK and QQQ have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CYTK has higher volatility (10.02%) compared to QQQ (8.71%). In terms of maximum drawdown, CYTK dropped -97.09% vs QQQ's -82.97%.

CYTK currently has the higher Sharpe Ratio (2.19 vs 1.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CYTK and QQQ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer